Nomura Holdings Inc. purchased a new position in Dolby Laboratories, Inc. (NYSE:DLB - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 7,918 shares of the electronics maker's stock, valued at approximately $618,000.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC grew its position in shares of Dolby Laboratories by 10,441,900.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 104,420 shares of the electronics maker's stock valued at $8,123,000 after purchasing an additional 104,419 shares during the period. Barclays PLC lifted its stake in Dolby Laboratories by 80.5% in the 3rd quarter. Barclays PLC now owns 33,230 shares of the electronics maker's stock valued at $2,544,000 after buying an additional 14,825 shares in the last quarter. AlphaQuest LLC boosted its holdings in Dolby Laboratories by 111.1% in the 4th quarter. AlphaQuest LLC now owns 6,148 shares of the electronics maker's stock worth $480,000 after buying an additional 3,235 shares during the last quarter. SG Americas Securities LLC purchased a new stake in Dolby Laboratories during the 4th quarter worth approximately $3,543,000. Finally, Twin Tree Management LP purchased a new stake in Dolby Laboratories during the 4th quarter worth approximately $662,000. Hedge funds and other institutional investors own 58.56% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. Barrington Research restated an "outperform" rating and issued a $100.00 target price on shares of Dolby Laboratories in a research report on Friday, May 2nd. Tigress Financial initiated coverage on shares of Dolby Laboratories in a research report on Thursday, May 15th. They set a "buy" rating and a $112.00 price target on the stock. Wall Street Zen lowered shares of Dolby Laboratories from a "strong-buy" rating to a "buy" rating in a research note on Friday, January 31st. Finally, Rosenblatt Securities reduced their price objective on Dolby Laboratories from $100.00 to $95.00 and set a "buy" rating on the stock in a research report on Friday, May 2nd.
Get Our Latest Analysis on Dolby Laboratories
Insider Transactions at Dolby Laboratories
In related news, SVP John D. Couling sold 675 shares of the business's stock in a transaction on Monday, May 5th. The shares were sold at an average price of $75.04, for a total transaction of $50,652.00. Following the completion of the transaction, the senior vice president now owns 121,151 shares in the company, valued at approximately $9,091,171.04. The trade was a 0.55% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 38.39% of the company's stock.
Dolby Laboratories Price Performance
DLB traded down $0.83 during trading hours on Monday, reaching $74.74. The company's stock had a trading volume of 324,323 shares, compared to its average volume of 451,966. The business's 50-day moving average is $76.01 and its 200-day moving average is $78.60. The stock has a market cap of $7.18 billion, a PE ratio of 27.48 and a beta of 0.95. Dolby Laboratories, Inc. has a fifty-two week low of $66.35 and a fifty-two week high of $89.66.
Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its earnings results on Thursday, May 1st. The electronics maker reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.29 by $0.05. Dolby Laboratories had a net margin of 19.97% and a return on equity of 11.32%. The firm had revenue of $369.56 million during the quarter, compared to the consensus estimate of $375.44 million. During the same quarter last year, the firm earned $1.27 EPS. The firm's revenue for the quarter was up 1.4% on a year-over-year basis. Analysts expect that Dolby Laboratories, Inc. will post 2.94 EPS for the current year.
Dolby Laboratories Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, May 21st. Investors of record on Tuesday, May 13th were paid a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 1.77%. The ex-dividend date of this dividend was Tuesday, May 13th. Dolby Laboratories's payout ratio is currently 49.81%.
About Dolby Laboratories
(
Free Report)
Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.
Read More

Before you consider Dolby Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dolby Laboratories wasn't on the list.
While Dolby Laboratories currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.